Overview

Galatea Bio builds diverse genomic data to power precision health. Its offerings include GB Community for diverse biobanking (starting with the Biobank of the Americas), GB Discovery to develop algorithms and pharmaceutical targets from the data, and GB Health to run a clinical lab delivering actionable results to clinics and pharma partners. The company collects DNA data from underrepresented populations, analyzes it to find genetic associations, and translates findings into drug targets and clinical tests. Its goal is to reduce health disparities by broadening genomic datasets and speeding up drug target discovery and actionable genomic results for partners.